CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration on Friday gave full approval for the marketing of Serostim for the treatment of HIV-related wasting. The compound received accelerated approval in 1996, a special regulatory status granted by the FDA for a drug used to treat patients with life-threatening illnesses. The full approval was based on a multi-center, placebo-controlled study of 757 HIV-positive people showing that the injectable medication is effective in increasing lean muscle mass and boosting weight in patients suffering from AIDS-related wasting. "We are very pleased that the FDA has granted full approval for Serostim," said James Sapirstein, executive vice president at Serono, the maker of the drug. "Wasting continues to be a major concern in the management of HIV and AIDS treatment, even with the benefits of highly active antiretroviral therapy. Serostim makes an important and positive difference in the physical endurance of people experiencing HIV wasting." Serostim is the only growth hormone approved by the FDA for the treatment of AIDS-related wasting. The drug is not available in Europe; in April 2003, the European Medicines Evaluation Agency rejected Serono's application to market the medication. About 6,000 HIV-positive people in the United States are prescribed Serostim. A 12-week course of the drug costs about $21,000.
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
These 15 major companies caved to the far right and stopped DEI programs
January 24 2025 1:11 PM
True
Latest Stories
JD Vance wants the UK to repeal its LGBTQ+ hate speech laws to secure a trade deal
April 17 2025 12:37 PM
Chicago Teachers Union ratifies groundbreaking contract cementing LGBTQ+ protections
April 17 2025 7:00 AM
Mahmoud v. Taylor: Everything to know about the Supreme Court case to ban LGBTQ+ books
April 17 2025 6:30 AM
Top 15 safest U.S. cities for LGBTQ+ travel
April 17 2025 6:02 AM
Federal government to remove gender dysphoria from protected disabilities list
April 16 2025 7:29 PM
U.S. activists call U.K. anti-trans ruling 'a serious blow' to human rights
April 16 2025 4:38 PM
Maine Gov. Janet Mills hits back after Trump sues state for transgender sports policies
April 16 2025 11:09 AM
'Protect the Dolls,' they said—so why was I yet at another trans memorial?
April 16 2025 7:00 AM
Marriage equality or same-sex marriage? Why the language matters
April 16 2025 6:00 AM